Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 877 record(s)

Req # A-2021-001811

Access to compliance audit results of cannabis facilities in Canada to better inform our documentation.

Organization: Health Canada

35 page(s)
June 2024

Req # A-2023-001456

A screenshot of the status page for the Third Desmopressin Abbreviated New Drug Submission (ANDS) on the Drug Submission Tracking System (DSTS) interface.

Organization: Health Canada

1 page(s)
June 2024

Req # A-2024-000151

Aggregate compliance and enforcement data related to Cannabis Regulations, Part 11.

Organization: Health Canada

2 page(s)
June 2024

Req # A-2022-001213

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-110998-499, Update on Reducing the Risk of Abuse of Cannabis Personal and Designated Production.

Organization: Health Canada

25 page(s)
June 2024

Req # A-2023-001545

Adverse Drug Reactions (ADRs). Report numbers: E2B_06110117, E2B_06001457.

Organization: Health Canada

41 page(s)
June 2024

Req # A-2023-000981

The Health Canada indication for Medical Device License (MDL) 69955, specifically, the Contour branded indication, Manufacturer PROLLENIUM MEDICAL TECHNOLOGIES INC.

Organization: Health Canada

57 page(s)
May 2024

Req # A-2023-001536

As part of its application to Health Canada for authorization to sell the COVID-19 lateral flow device with the Interim Order (IO) authorization Identification 327866, the manufacturer sent the federal government about 200 sample tests. Provide the…

Organization: Health Canada

8 page(s)
May 2024

Req # A-2023-001537

As part of its application to Health Canada for authorization to sell the three COVID-19 lateral flow devices with the Interim Order (IO) authorization Identifications 313054, 328889, and 333956, the manufacturer sent the federal government about…

Organization: Health Canada

8 page(s)
May 2024

Req # A-2022-001452

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-075408-992, Deputy Ministerial Meeting with DNAStack.

Organization: Health Canada

3 page(s)
May 2024

Req # A-2023-001583

Adverse Drug Reaction (ADR) for Isentress. Report number: E2B_ 00310522.

Organization: Health Canada

9 page(s)
May 2024
Date modified: